Partnerships
Avantium Pharma aims at creating value by uncovering significant clinical and patient benefit via novel solid forms of marketed drugs in combination with alternative formulations or delivery routes.
Patient benefits are the key driver of our program and these may result from improved drug products that
- have a better efficacy and toxicity profile
- have an alternative administration route
- are geared towards specific patient populations
- increase compliance
- address new therapeutic indications
A novel solid form with suitable properties is often the key to successful development of novel formulations or alternative administration routes that enhance the therapeutic application of a drug product. Avantium has a proven track record in the identification of novel solid forms of active pharmaceutical ingredients which include polymorphs, salts, co‑crystals and amorphous solid dispersions.
Avantium seeks to establish partnerships with companies that share the same vision in order to accelerate in a joint effort the realization of the common goal. We collaborate with drug delivery, formulation or specialty Pharma companies possessing advanced technologies for pharmaceutical development.
